Holding(s) in Company

IP2IPO Group PLC 22 March 2005 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company IP2IPO Limited 2. Name of shareholder having a major interest Merrill Lynch & Co. Inc. 3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 On behalf of certain discretionary management clients who are invested in an unauthorised unit trust of which Merrill Lynch are the investment manager. 4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them Nutraco Nominees Limited (Designated & Underdesignated) 4,289,151 Merrill Lynch Pension Nominees Limited A/C NONCERT 732,808 Royal Bank of Scotland as Trustees of Merrill Lynch UK Dynamic Fund 1,944,234 5. Number of shares / amount of stock acquired Nutraco Nominees Limited (Designated & Underdesignated) 1,236,330 Merrill Lynch Pension Nominees Limited A/C NONCERT 227,378 Royal Bank of Scotland as Trustees of Merrill Lynch UK Dynamic Fund 490,423 6. Percentage of issued class Nutraco Nominees Limited (Designated & Underdesignated) 2.86% Merrill Lynch Pension Nominees Limited A/C NONCERT 0.53% Royal Bank of Scotland as Trustees of Merrill Lynch UK Dynamic Fund 1.14% 7. Number of shares / amount of stock disposed N/A 8. Percentage of issued class N/A 9. Class of security 10p Ordinary Shares 10. Date of transaction Not notified 11. Date company informed 22 March 2005 12. Total holding following this notification 6,966,193 13. Total percentage holding of issued class following this notification 16.14% 14. Any additional information - 15. Name of contact and telephone number for queries John Davies Finance Director 0207 067 1664 16. Name and signature of authorised company official responsible for making this notification John Davies Date of notification 22 March 2005 The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material. This information is provided by RNS The company news service from the London Stock Exchange

Companies

IP Group (IPO)
UK 100